BioAffinity Technologies IncBIAF
Price$6.14

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5.7M-26.3% YoYTTM through 31 Mar 2026
Net Income -$15.8MTTM through 31 Mar 2026
Free Cash Flow -$12.5MTTM through 31 Mar 2026

Margins

Current
Gross Margin74.5%
Operating Margin-267.6%
Net Margin-268.6%

Returns

-99.2%ROE
-200.0%ROA

Balance Sheet Health

Debt / Equity0.38x
Current Ratio1.36x
Net Debt-$1.7Mnet cash position
Cash & Equivalents$3.1M

Quality Metrics

FCF Margin-221.7%
Earnings-Beat Rate0.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.